精确医学在风湿性关节炎相关的间歇性肺病:当前的证据和未来的方向
1University of Kansas Medical Center, Department of Medicine, Division of Pulmonary, Critical Care and Sleep. 3901 Rainbow Blvd, Kansas City, Kansas, USA.
Current opinion in pulmonary medicine
|June 23, 2025
概括
精准医学为与类风湿性关节炎相关的间歇性肺病 (RA-ILD) 提供了新的希望. 整合分子数据和有针对性的试验可以个性化治疗,改善这种严重疾病的生存率.
科学领域:
- 肺部医学 肺部医学
- 类风湿病学 类风湿病学
- 精准医学是一门精准的医学.
背景情况:
- 风湿性关节炎相关的间歇性肺病 (RA-ILD) 预后不佳,基于证据的治疗方法有限.
- 对于RA-ILD的最佳管理策略仍然不确定,这突显了迫切的临床需求.
研究的目的:
- 本综述探讨了RA-ILD的新兴精准医学方法.
- 目标是指导RA-ILD患者更有效,个性化的治疗决策.
主要方法:
- 审查了精准医学对类风湿性关节炎 (RA) 关节疾病的进展.
- 审查新兴生物标志物,如白细胞端粒长度,蛋白质组学和基于肺的系统生物学.
- 考虑综合分子表型和向试验的多模式方法.
主要成果:
- 目前基于成像的RA-ILD治疗缺乏验证,并无法预测反应.
- 精准医学在RA关节中确定了预测治疗反应的分子亚型.
- 新的生物标志物显示出揭示RA-ILD分子异质性和指导治疗的潜力.
结论:
- 结合分子表型和向试验的多模式策略对于RA-ILD的进展至关重要.
- 通过支气管镜检查直接分析疾病区块,可以提供超越外围生物标志物的洞察力.
- 生物标志物分层试验对于解决临床平衡和提高结果至关重要.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
629
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
629
Rheumatic Heart Disease III: Medical Management
36
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
36
Asthma: Pathogenesis and Management
618
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
618
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K


